These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23425057)

  • 21. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
    Mazumder NR; Atiemo K; Daud A; Kho A; Abecassis M; Levitsky J; Ladner DP
    Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copeptin - a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease.
    Schneider C; Remmler J; Netto J; Seehofer D; Engelmann C; Berg T; Thiery J; Kaiser T
    Clin Chem Lab Med; 2019 Nov; 57(12):1897-1905. PubMed ID: 31199758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score?
    Chen YW; Chang CW; Chang CW; Wang TE; Wu CJ; Chen HH
    World J Hepatol; 2012 Nov; 4(11):291-8. PubMed ID: 23293714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding.
    Tantai XX; Liu N; Yang LB; Wei ZC; Xiao CL; Song YH; Wang JH
    World J Gastroenterol; 2019 Dec; 25(45):6668-6680. PubMed ID: 31832005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases.
    El-Ghannam MT; Hassanien MH; El-Talkawy MD; Saleem AAA; Sabry AI; Abu Taleb HM
    J Clin Diagn Res; 2017 Jun; 11(6):OC12-OC16. PubMed ID: 28764217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different scoring systems to predict 6-week mortality in cirrhosis patients with acute variceal bleeding: a retrospective analysis of 202 patients.
    Wang F; Cui S; Wang F; Li F; Tang F; Zhang X; Gao Y; Lv H
    Scand J Gastroenterol; 2018; 53(7):885-890. PubMed ID: 29911438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality.
    Kanwal F; Taylor TJ; Kramer JR; Cao Y; Smith D; Gifford AL; El-Serag HB; Naik AD; Asch SM
    JAMA Netw Open; 2020 Nov; 3(11):e2023780. PubMed ID: 33141161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective and prospective validation of model for end-stage liver disease (MELD) score in predicting mortality in patients of alcoholic liver disease.
    Mallaiyappan M; Sawalakhe NR; Sasidharan M; Shah DK; Rathi PM; Bhatia SJ
    Trop Gastroenterol; 2013; 34(4):252-8. PubMed ID: 25046888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].
    Zhang JY; Qin CY; Jia JD; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):108-11. PubMed ID: 22464781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis.
    Cavallazzi R; Awe OO; Vasu TS; Hirani A; Vaid U; Leiby BE; Kraft WK; Kane GC
    J Crit Care; 2012 Aug; 27(4):424.e1-6. PubMed ID: 22227088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy.
    Wang J; Wang AJ; Li BM; Liu ZJ; Chen L; Wang H; Shi F; Zhu X
    J Clin Gastroenterol; 2014; 48(10):870-7. PubMed ID: 24296420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.
    Benedeto-Stojanov D; Nagorni A; Bjelaković G; Stojanov D; Mladenović B; Djenić N
    Vojnosanit Pregl; 2009 Sep; 66(9):724-8. PubMed ID: 19877551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy.
    Wu SL; Zheng YX; Tian ZW; Chen MS; Tan HZ
    World J Clin Cases; 2018 Dec; 6(15):995-1006. PubMed ID: 30568954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward.
    Barosa R; Roque Ramos L; Patita M; Nunes G; Fonseca J
    Rev Esp Enferm Dig; 2017 Jun; 109(6):399-405. PubMed ID: 28467096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis.
    Chirapongsathorn S; Bunraksa W; Chaiprasert A; Punpanich D; Supasyndh O; Kamath PS
    J Gastroenterol Hepatol; 2018 Mar; 33(3):726-732. PubMed ID: 28840619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prognostic value of end-stage liver disease model in liver cirrhosis].
    Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.